
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers
Author(s) -
Alice Asher,
Glenn-Milo Santos,
Jennifer L. Evans,
E. Kainne Dokubo,
TzongHae Lee,
Jeffrey N. Martin,
Steven G. Deeks,
Leslie H. Tobler,
Michael P. Busch,
Peter W. Hunt,
Kimberly Page
Publication year - 2013
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/01.aids.0000433242.86362.21
Subject(s) - immunology , human leukocyte antigen , hepatitis c virus , medicine , hepatitis c , genotype , virology , biology , virus , antigen , biochemistry , gene
HIV controllers demonstrate high rates of spontaneous clearance of hepatitis C virus (HCV) infection. The objective of this study was to evaluate the role of human leukocyte antigen (HLA) B*57 and other genetic polymorphisms on HCV clearance in HIV controllers.